97,600 Shares in Kenvue Inc. $KVUE Acquired by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System bought a new position in shares of Kenvue Inc. (NYSE:KVUE) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 97,600 shares of the company’s stock, valued at approximately $1,683,000.

A number of other large investors have also made changes to their positions in the stock. Physician Wealth Advisors Inc. grew its stake in shares of Kenvue by 67.5% in the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after buying an additional 618 shares during the period. Elyxium Wealth LLC purchased a new stake in shares of Kenvue during the 4th quarter valued at approximately $26,000. MV Capital Management Inc. acquired a new position in Kenvue in the fourth quarter valued at approximately $28,000. Reflection Asset Management acquired a new position in Kenvue in the fourth quarter valued at approximately $32,000. Finally, SBI Securities Co. Ltd. grew its position in Kenvue by 82.4% in the fourth quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock worth $39,000 after acquiring an additional 1,027 shares during the period. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.59% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms have commented on KVUE. Citigroup decreased their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Barclays cut their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. Argus upgraded shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. Zacks Research upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. Finally, UBS Group lowered their target price on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $19.33.

Kenvue Stock Up 1.1%

KVUE stock opened at $19.33 on Thursday. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $22.87. The company has a market cap of $37.11 billion, a price-to-earnings ratio of 22.74, a price-to-earnings-growth ratio of 1.45 and a beta of 0.54. The company has a fifty day moving average price of $17.76 and a 200 day moving average price of $17.68. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. During the same quarter in the previous year, the firm earned $0.24 earnings per share. The firm’s revenue was up 4.5% on a year-over-year basis. Sell-side analysts expect that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were issued a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.3%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is presently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.